Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Diabetic    crawled time : 22:07    save search

Nevro Announces FDA Submission for HF10® Therapy in Patients with Painful Diabetic Neuropathy
Published: 2020-12-28 (Crawled : 22:07) - prnewswire.com
NVRO | $12.07 -2.03% 0.0% 390K twitter stocktwits trandingview |
Health Technology
| | O: 0.31% H: 0.69% C: -1.36%

fda submission diabetic therapy diabetes
Gainers vs Losers
67% 33%

Top 10 Gainers

Your saved searches
Save your searches and get alerts when important news are released.